AM-5308

CAS No. 2410796-89-1

AM-5308( —— )

Catalog No. M35734 CAS No. 2410796-89-1

AM-5308 is a kinesin KIF18A inhibitor that can be used to study cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 225 Get Quote
5MG 353 Get Quote
10MG 534 Get Quote
25MG 1030 Get Quote
50MG 1638 Get Quote
100MG 2592 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    AM-5308
  • Note
    Research use only, not for human use.
  • Brief Description
    AM-5308 is a kinesin KIF18A inhibitor that can be used to study cancer.
  • Description
    AM-5308 is a potent kinesin KIF18A inhibitor (WO2021211549A1, C13).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Microtubule Associated
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2410796-89-1
  • Formula Weight
    529.65
  • Molecular Formula
    C26H35N5O5S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (188.80 mM; Ultrasonic )
  • SMILES
    C(NC=1N=C(C=CC1)N2C[C@@H](C)OCC2)(=O)C3=C(N4CCC5(CC5)CC4)C=C(NS(CCO)(=O)=O)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Marc Noel PAYTON, et al. Kif18a inhibitors for treatment of neoplastic diseases. WO2021211549A1.
molnova catalog
related products
  • Substance P (7-11)

    Substance P (7-11) is a C-terminal fragment of Substance P, which can cause an increase in the intracellular calcium concentration as measured by the fluorescent dye Fura-2. In addition, the C-terminal fragment of SP, SP-(7-11), increased PGE2 and collagenase production at concentrations greater than 1 mM.

  • Boc-GRR-AMC

    Boc-GRR-AMC is a tri-peptide Substrate. Boc-GRR-AMC can be used for a fluorogenic West Nile virus (WNV) substrate, profiling the substrate specificity for the NS2B-NS3 proteases or determining the pH optimum of LdMC activity.

  • [Nle253]-HSV-1 UL 26...

    [Nle253]-HSV-1 UL 26 Open Reading Frame (238-257)